Husam Alzayer
@husamjz.bsky.social
#Nephrologist on a learning mission! #KIreports graphic designer, #NSMC #NephEdC faculty, and #NephJC team member
Reposted by Husam Alzayer
Tonite 11/18/25 on #Bluesky 9pm EST
We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
Attacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJC
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
www.nephjc.com
November 18, 2025 at 12:29 PM
Tonite 11/18/25 on #Bluesky 9pm EST
We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
Reposted by Husam Alzayer
Check out the awesome visual abstract by @salinesolut.bsky.social
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
ORIGIN-3: The Visual Abstract — NephJC
Atacicept, BAFF/APRIL inhibition in IgAN
www.nephjc.com
November 18, 2025 at 12:32 PM
Check out the awesome visual abstract by @salinesolut.bsky.social
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
Reposted by Husam Alzayer
📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Impact of Donor and Recipient Diabetes on Posttransplant Outcomes: Gradually Seeing the Wood for the Trees www.kireports.org/ar...
@husamjz.bsky.social
@husamjz.bsky.social
November 7, 2025 at 9:00 AM
📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Impact of Donor and Recipient Diabetes on Posttransplant Outcomes: Gradually Seeing the Wood for the Trees www.kireports.org/ar...
@husamjz.bsky.social
@husamjz.bsky.social
Glad to share our recent publication of diffuse cortical necrosis in native kidneys of a patient with #sickle_cell_trait.
Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients.
karger.com/cnd/article/...
Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients.
karger.com/cnd/article/...
Diffuse Cortical Necrosis of Native Kidneys in Sickle Cell Trait: A Case Report
Abstract. Introduction: Sickle cell disorders are the most common hereditary hematological disorders; sickle cell trait (SCT) is largely benign with mild clinical manifestations, if any. Renal cortica...
karger.com
October 31, 2025 at 4:56 AM
Glad to share our recent publication of diffuse cortical necrosis in native kidneys of a patient with #sickle_cell_trait.
Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients.
karger.com/cnd/article/...
Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients.
karger.com/cnd/article/...
Reposted by Husam Alzayer
🧵Tweetorial Alert 🧵
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
September 30, 2025 at 5:07 PM
🧵Tweetorial Alert 🧵
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
Reposted by Husam Alzayer
Check out the latest @kireports.bsky.social community blog from @husamjz.bsky.social
Anticoagulantion in ESRD patients with atrial fibrillation:
www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g
Anticoagulantion in ESRD patients with atrial fibrillation:
www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g
Bleeding, Clotting, and Kidney Disease in Atrial Fibrillation: Can Factor XI Inhibitors Change the Game?
By. Husam Alzayer, MD, MSc, MRCPIReviewed by Sophia Ambruso, DOIntroduction Bleeding and thrombosis represent one of the many paradoxes faced by patients with kidney disease. As kidney function declin...
www.kireportscommunity.org
September 8, 2025 at 11:36 PM
Check out the latest @kireports.bsky.social community blog from @husamjz.bsky.social
Anticoagulantion in ESRD patients with atrial fibrillation:
www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g
Anticoagulantion in ESRD patients with atrial fibrillation:
www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g
Reposted by Husam Alzayer
1/10
Last #NephJC we discussed the use of nudges 🫵 #TenPostNephJC
In this study e-nudges (email) were sent to general practitioners (GPs) & patients to see if the uptake of goal-directed medical therapy (GDMT) in diabetic CKD could be increased.
Read the article 👇
pubmed.ncbi.nlm.nih.gov/40481660/
Last #NephJC we discussed the use of nudges 🫵 #TenPostNephJC
In this study e-nudges (email) were sent to general practitioners (GPs) & patients to see if the uptake of goal-directed medical therapy (GDMT) in diabetic CKD could be increased.
Read the article 👇
pubmed.ncbi.nlm.nih.gov/40481660/
June 25, 2025 at 4:47 PM
1/10
Last #NephJC we discussed the use of nudges 🫵 #TenPostNephJC
In this study e-nudges (email) were sent to general practitioners (GPs) & patients to see if the uptake of goal-directed medical therapy (GDMT) in diabetic CKD could be increased.
Read the article 👇
pubmed.ncbi.nlm.nih.gov/40481660/
Last #NephJC we discussed the use of nudges 🫵 #TenPostNephJC
In this study e-nudges (email) were sent to general practitioners (GPs) & patients to see if the uptake of goal-directed medical therapy (GDMT) in diabetic CKD could be increased.
Read the article 👇
pubmed.ncbi.nlm.nih.gov/40481660/
Reposted by Husam Alzayer
👉We all need little nudges to do the right thing.
Join us 6/24/25 at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephSky
Blog by @nephroseeker.medsky.social @dramiliflores.bsky.social @husamjz.bsky.social
www.nephjc.com/news/nudge-ckd
Join us 6/24/25 at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephSky
Blog by @nephroseeker.medsky.social @dramiliflores.bsky.social @husamjz.bsky.social
www.nephjc.com/news/nudge-ckd
Are E-Nudges Enough to Push Guideline-Based CKD Therapy? — NephJC
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
www.nephjc.com
June 24, 2025 at 2:42 AM
👉We all need little nudges to do the right thing.
Join us 6/24/25 at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephSky
Blog by @nephroseeker.medsky.social @dramiliflores.bsky.social @husamjz.bsky.social
www.nephjc.com/news/nudge-ckd
Join us 6/24/25 at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephSky
Blog by @nephroseeker.medsky.social @dramiliflores.bsky.social @husamjz.bsky.social
www.nephjc.com/news/nudge-ckd
Reposted by Husam Alzayer
Kidney Outcomes in Patients With Hereditary #Transthyretin #Amyloid Nephropathy Treated With Transthyretin #Stabilizers And Gene-Silencer Therapies
#VisualAbstract by @Husamjz
www.kireports.org/ar...
#VisualAbstract by @Husamjz
www.kireports.org/ar...
April 21, 2025 at 3:00 PM
Kidney Outcomes in Patients With Hereditary #Transthyretin #Amyloid Nephropathy Treated With Transthyretin #Stabilizers And Gene-Silencer Therapies
#VisualAbstract by @Husamjz
www.kireports.org/ar...
#VisualAbstract by @Husamjz
www.kireports.org/ar...
Reposted by Husam Alzayer
🔔Skeetorial Alert 🔔
1/
Hey #NephSky #MedSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
1/
Hey #NephSky #MedSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
April 4, 2025 at 4:09 AM
🔔Skeetorial Alert 🔔
1/
Hey #NephSky #MedSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
1/
Hey #NephSky #MedSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
Reposted by Husam Alzayer
Happening this week!
The @kdigo.org guidelines in #ADPKD #PKD on #NephJC
www.nephjc.com/news/adpkd-k...
Summary from @brianrifkin.bsky.social
The @kdigo.org guidelines in #ADPKD #PKD on #NephJC
www.nephjc.com/news/adpkd-k...
Summary from @brianrifkin.bsky.social
KDIGO 2025 ADPKD Guidelines Review — NephJC
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, ...
www.nephjc.com
March 24, 2025 at 1:30 PM
Happening this week!
The @kdigo.org guidelines in #ADPKD #PKD on #NephJC
www.nephjc.com/news/adpkd-k...
Summary from @brianrifkin.bsky.social
The @kdigo.org guidelines in #ADPKD #PKD on #NephJC
www.nephjc.com/news/adpkd-k...
Summary from @brianrifkin.bsky.social
Reposted by Husam Alzayer
They're trying to deport my colleague from the med school and holding her without counsel. She was coming back from a visit to her family. If there are ways to help I'll let you know. www.providencejournal.com/story/news/l...
She saw family in Lebanon. Now this Brown Medicine doctor is being held at Logan for deportation.
Dr. Rasha Alawieh flew into Logan Airport Thursday after visiting family in Lebanon. She's being detained now at Logan without legal counsel.
www.providencejournal.com
March 15, 2025 at 4:06 AM
Reposted by Husam Alzayer
Interaction Between #APOL1 #Genetic Risk and Neighborhood Socioeconomic Status for #Kidney Outcomes in a United States Cohort
#VisualAbstract by @husamjz.bsky.social
www.kireports.org/ar...
#VisualAbstract by @husamjz.bsky.social
www.kireports.org/ar...
March 12, 2025 at 3:00 PM
Interaction Between #APOL1 #Genetic Risk and Neighborhood Socioeconomic Status for #Kidney Outcomes in a United States Cohort
#VisualAbstract by @husamjz.bsky.social
www.kireports.org/ar...
#VisualAbstract by @husamjz.bsky.social
www.kireports.org/ar...
Reposted by Husam Alzayer
Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces
www.nephjc.com/intern-app for details and to apply!
#NephSky
www.nephjc.com/intern-app for details and to apply!
#NephSky
NephJC Editorial Internship — NephJC
www.nephjc.com
March 6, 2025 at 6:16 PM
Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces
www.nephjc.com/intern-app for details and to apply!
#NephSky
www.nephjc.com/intern-app for details and to apply!
#NephSky
Reposted by Husam Alzayer
Systematic Review of the Effects of #Iron on #Cardiovascular, #Kidney and Safety Outcomes in Patients With Chronic Kidney Disease #CKD
#VisualAbstract by @Husamjz
www.kireports.org/ar...
@bernardchan33 @brendonneuen
#VisualAbstract by @Husamjz
www.kireports.org/ar...
@bernardchan33 @brendonneuen
February 14, 2025 at 3:01 PM
Systematic Review of the Effects of #Iron on #Cardiovascular, #Kidney and Safety Outcomes in Patients With Chronic Kidney Disease #CKD
#VisualAbstract by @Husamjz
www.kireports.org/ar...
@bernardchan33 @brendonneuen
#VisualAbstract by @Husamjz
www.kireports.org/ar...
@bernardchan33 @brendonneuen
Reposted by Husam Alzayer
#Pharmacokinetics and #SideEffects of Δ9-tetrahydrocannabinol and #Cannabidiol in Patients with Different Stages of Chronic Kidney Disease #CKD
#VisualAbstract by @Husamjz
www.kireports.org/ar...
#VisualAbstract by @Husamjz
www.kireports.org/ar...
January 8, 2025 at 3:00 PM
#Pharmacokinetics and #SideEffects of Δ9-tetrahydrocannabinol and #Cannabidiol in Patients with Different Stages of Chronic Kidney Disease #CKD
#VisualAbstract by @Husamjz
www.kireports.org/ar...
#VisualAbstract by @Husamjz
www.kireports.org/ar...
Reposted by Husam Alzayer
1/ 🚨 NEW #5Pearls: Peripheral Artery Disease (PAD)
Let’s learn:
🚦When to suspect PAD
🚦PAD workup
🚦How to ⬆️ quality of life
🚦How to ⬇️ CV mortality
🚦Role of anti-thrombotics & anticoagulation
🚦Who needs revascularization
🖥️: t.co/dXfmA3Wx3c
Let’s learn:
🚦When to suspect PAD
🚦PAD workup
🚦How to ⬆️ quality of life
🚦How to ⬇️ CV mortality
🚦Role of anti-thrombotics & anticoagulation
🚦Who needs revascularization
🖥️: t.co/dXfmA3Wx3c
https://www.coreimpodcast.com/2024/11/27/peripheral-arterial-disease-5-pearls-segment/
t.co
November 27, 2024 at 12:03 PM
1/ 🚨 NEW #5Pearls: Peripheral Artery Disease (PAD)
Let’s learn:
🚦When to suspect PAD
🚦PAD workup
🚦How to ⬆️ quality of life
🚦How to ⬇️ CV mortality
🚦Role of anti-thrombotics & anticoagulation
🚦Who needs revascularization
🖥️: t.co/dXfmA3Wx3c
Let’s learn:
🚦When to suspect PAD
🚦PAD workup
🚦How to ⬆️ quality of life
🚦How to ⬇️ CV mortality
🚦Role of anti-thrombotics & anticoagulation
🚦Who needs revascularization
🖥️: t.co/dXfmA3Wx3c
Reposted by Husam Alzayer
If you haven't already - please consider signing the ISN petition for the WHO to consider kidney health as a global priority
We explain why with link to sign (takes 2 minutes - open to all)
www.nephjc.com/news/isn-who...
We explain why with link to sign (takes 2 minutes - open to all)
www.nephjc.com/news/isn-who...
Making Kidney Health a Global Priority — NephJC
Let’s pus the WHO to make Kidney Health a global priority
www.nephjc.com
November 10, 2024 at 1:33 AM
If you haven't already - please consider signing the ISN petition for the WHO to consider kidney health as a global priority
We explain why with link to sign (takes 2 minutes - open to all)
www.nephjc.com/news/isn-who...
We explain why with link to sign (takes 2 minutes - open to all)
www.nephjc.com/news/isn-who...